Company
Enliven Therapeutics Inc ELVN
Tracked across 2 disclosed holders on Protégé.
Held by these investors
| Investor | % of portfolio | Value |
|---|---|---|
| Samlyn Capital | 0.8% | $46.3M |
| Baker Brothers Investments | 0.2% | $45.9M |
Company
Tracked across 2 disclosed holders on Protégé.
| Investor | % of portfolio | Value |
|---|---|---|
| Samlyn Capital | 0.8% | $46.3M |
| Baker Brothers Investments | 0.2% | $45.9M |